Are you fully exploring the potential of NK mediated therapeutics?
Case Study // 08.09.24

Are you fully exploring the potential of NK mediated therapeutics?

At Nexus BioQuest, our scientists are experts in NK cell biology and offer a comprehensive suite of assays to test novel therapeutics. View our case study to see how NK cell driven ADCC is being developed for oncology and autoimmunity; targeting either unwanted tumour cells or autoreactive immune cells.

Download case study
Related Resources
Modulation of inflammatory or anti-inflammatory M1/ M2a-d function
Case Study // 08.09.24
Modulation of inflammatory or anti-inflammatory M1/ M2a-d function
Macrophages are highly plastic and can differentiate into a range of activated phenotypes driven by external signals under various disease conditions. Therapeutic driven modulation of macrophage phenotype has the potential to modulate many different disease types where macrophage play a key role in either driving or regulating disease. We present here a range of macrophage […]
Read More
Therapeutic Targeting of Neutrophil Netosis and Phagocytosis
Case Study // 08.09.24
Therapeutic Targeting of Neutrophil Netosis and Phagocytosis
Neutrophils are amongst the first immune cells to respond to injury or infection. Armed with a variety of effector mechanisms, they release neutrophil extracellular traps (NETs), comprising of chromatin and antimicrobial proteins which are released via a unique, pro-inflammatory form of cell death called NETosis. Dysregulated NET release can damage the host, contributing to autoimmune […]
Read More

Drug Discovery Tool

Find the right immune assay for your therapeutic area, modality and target using this interactive Drug Discovery Tool.

Explore now
Speak to a Scientist

Learn how the Nexus BioQuest team can help with your pre-clinical drug discovery programs.

Schedule a call